12 Jan
BREAKING NEWS Hadassah together with Bar Ilan University have successfully developed an immunotherapy treatment for Multiple Myeloma by “reprogramming the immune systems” of cancer patients, with a US-based pharma company licensing it for commercialisation. The treatment involves removing healthy white blood cells — T-cells — from cancer patients and adding an artificial molecule before […]
READ MORE14 Jan
Dr. Gal Goldstein, Head of Hadassah’s Dyna & Fala Weinstock Department of Paediatric Haemato-Oncology. (photo credit: MARC ISRAEL SELLEM) Hadassah invested a lot of energy, time and money to re-establish the department. BY RIVKAH LAMBERT ADLER Jerusalem Post JANUARY 5, 2019 You wouldn’t think a paediatric oncology department would be a laughter-filled place, but Nurse […]
READ MOREHadassah UK © 2022 | w/creators with Web Studio Lab
Join our digital newsletter to stay in touch with the latest news from Hadassah UK